CDEK by Data4ThePeople

Sign in Sign up

← All organizations

Adicet Bio

For profitWebsite ↗

Also known as: Adicet Bio | Adicet Bio, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 1

First clinical trial

Last known activity

Mar 4, 2021

Timeline

2010s

Jun 1, 2014
Adicet Bio— Founded

2020s

Apr 29, 2020
resTORbio, Inc.— Acquired

Drugs by trial phase (8 distinct, 6 trials)

Phase 3 (0 own, 2 via acquisition)

Phase 2 (0 own, 1 via acquisition)

everolimus

Phase 1 (5 own, 0 via acquisition)

Subsidiaries (1 direct, 1 total across the full acquisition tree)

resTORbio, Inc.

Recent trials (2)

NCT04735471Lead sponsorPhase 1Mar 4, 2021
NCT04735471Study directorPhase 1Mar 4, 2021

Details

Founded: New York, NY, US Jun 1, 2014
Last known activity: Mar 4, 2021